Hoth Therapeutics Files 8-K
Ticker: HOTH · Form: 8-K · Filed: Feb 7, 2025 · CIK: 1711786
| Field | Detail |
|---|---|
| Company | Hoth Therapeutics, Inc. (HOTH) |
| Form Type | 8-K |
| Filed Date | Feb 7, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $5,000,000, $2,700,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Disclosure
Related Tickers: HOTH
TL;DR
HOTH filed an 8-K on 2/7/25, check for updates.
AI Summary
Hoth Therapeutics, Inc. filed an 8-K on February 7, 2025, reporting other events and financial statements/exhibits. The filing does not contain specific financial figures or details about the 'other events' within the provided text.
Why It Matters
This filing indicates Hoth Therapeutics is providing updates or disclosures to the SEC, which could be significant for investors monitoring the company's activities.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and financial statements, lacking specific material information in the provided text.
Key Players & Entities
- Hoth Therapeutics, Inc. (company) — Registrant
- February 7, 2025 (date) — Date of Report
- Nevada (jurisdiction) — State of Incorporation
- 1177 Avenue of the Americas (address) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported by Hoth Therapeutics in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'Other Events' being reported.
When was this 8-K filing submitted to the SEC?
The filing was submitted on February 7, 2025.
What is the principal executive office address for Hoth Therapeutics, Inc.?
The principal executive offices are located at 1177 Avenue of the Americas, 5th Floor, Suite 5066, New York, NY 10036.
In which state is Hoth Therapeutics, Inc. incorporated?
Hoth Therapeutics, Inc. is incorporated in Nevada.
What is the SIC code for Hoth Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Hoth Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 521 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2025-02-07 16:18:10
Key Financial Figures
- $0.0001 — nge on which registered Common stock, $0.0001 par value HOTH The Nasdaq Stock Mar
- $5,000,000 — 24, to up to an additional aggregate of $5,000,000, which does not include the approximate
- $2,700,000 — hich does not include the approximately $2,700,000 of shares of common stock that were sol
Filing Documents
- ea0230283-8k_hoth.htm (8-K) — 35KB
- ea023028301ex5-1_hoth.htm (EX-5.1) — 15KB
- ex5-1_001.jpg (GRAPHIC) — 8KB
- 0001213900-25-011325.txt ( ) — 240KB
- hoth-20250207.xsd (EX-101.SCH) — 3KB
- hoth-20250207_lab.xml (EX-101.LAB) — 33KB
- hoth-20250207_pre.xml (EX-101.PRE) — 22KB
- ea0230283-8k_hoth_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 7, 2025 Hoth Therapeutics, Inc. /s/ Robb Knie Robb Knie Chief Executive Officer 2